Centrose, a Madison start-up focused on enhancing drugs with sugar biology, has announced it has raised about $2.1 million in angel investment funds, at a time when such funding is not easy to come by.
- Inside Wis: Keeping up higher ed investments will help meet workforce needsOctober 20, 2017
- BrightStar’s Shannon to join Investor Hall of FameOctober 20, 2017
- Emerging firms will pitch over two days at 2017 Wisconsin Early Stage SymposiumOctober 19, 2017
- ‘Stubborn’ trep Sikes on tap for Nov. 14 WOMEN receptionOctober 13, 2017
- Tom Still on WEDWisconsin and the Early Stage SymposiumOctober 13, 2017